Skip to main content
OpenTrials

Clinical trial condition

Genital Neoplasms, Male

Explore clinical trials studying Genital Neoplasms, Male. Study availability and eligibility vary by location and protocol.

5,032 public trials 1,031 recruiting studies
Refine in advanced search Browse all conditions

Genital Neoplasms, Male trial results

Completed

Study of Pembrolizumab (MK-3475) Plus Docetaxel Versus Placebo Plus Docetaxel in Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-3475-921/KEYNOTE-921)

NCT03834506

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations
  • University of South Alabama, Mitchell Cancer Institute ( Site 0065) Mobile, Alabama, United States
  • St. Joseph Heritage Healthcare ( Site 0069) Fullerton, California, United States
  • University of Southern California Norris Comprehensive Cancer Center ( Site 0061) Los Angeles, California, United States
  • USC Norris Oncology Hematology Newport Beach ( Site 0093) Newport Beach, California, United States
View all 215 locations
View Trial Details
Completed

Effect of Treatment on Work Experience in Patients With Stage I-III Prostate Cancer

NCT03963739

Conditions
Adenocarcinoma, Carcinoma, Genital Diseases, +15 more
Locations
  • Cancer Center at Saint Joseph's Phoenix, Arizona, United States
  • Mercy Hospital Fort Smith Fort Smith, Arkansas, United States
  • CHI Saint Vincent Cancer Center Hot Springs Hot Springs, Arkansas, United States
  • Kaiser Permanente-Anaheim Anaheim, California, United States
View all 326 locations
View Trial Details
Completed

BI836845 Plus Enzalutamide in Castrate Resistant Prostate Cancer (CRPC)

NCT02204072

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations
  • Karmanos Cancer Institute Detroit, Michigan, United States
  • NewYork-Presbyterian/Weill Cornell Medical Center New York, United States
  • Oregon Health and Sciences University Portland, Oregon, United States
  • Prince of Wales Hospital Hong Kong
View all 27 locations
View Trial Details
Completed

Efficacy of [18F]PSMA-1007 PET/CT in Patients With Biochemial Recurrent Prostate Cancer

NCT04742361

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +9 more
Locations
  • Mayo Clinic Rochester, Minnesota, United States
  • MD Anderson Cancer Center Houston, Texas, United States
  • Excel Diagnostics and Nuclear Oncology Center Houston, Texas, United States
  • Huntsman Cancer Institute Salt Lake City, Utah, United States
View Trial Details

Related conditions